600 Shares in Mettler-Toledo International, Inc. $MTD Purchased by S&CO Inc.

S&CO Inc. bought a new stake in Mettler-Toledo International, Inc. (NYSE:MTD) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 600 shares of the medical instruments supplier’s stock, valued at approximately $766,000.

Other institutional investors also recently made changes to their positions in the company. Aware Super Pty Ltd as trustee of Aware Super acquired a new stake in shares of Mettler-Toledo International in the 1st quarter worth about $26,372,000. M&T Bank Corp boosted its stake in Mettler-Toledo International by 2,813.6% during the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock valued at $173,165,000 after purchasing an additional 119,942 shares during the period. Strs Ohio boosted its stake in Mettler-Toledo International by 2,594.8% during the 4th quarter. Strs Ohio now owns 13,393 shares of the medical instruments supplier’s stock valued at $18,672,000 after purchasing an additional 12,896 shares during the period. Crossmark Global Holdings Inc. grew its position in Mettler-Toledo International by 34.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 4,150 shares of the medical instruments supplier’s stock worth $5,786,000 after purchasing an additional 1,060 shares during the last quarter. Finally, KBC Group NV grew its position in Mettler-Toledo International by 22.9% in the 4th quarter. KBC Group NV now owns 8,089 shares of the medical instruments supplier’s stock worth $11,278,000 after purchasing an additional 1,507 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,417.40 on Monday. Mettler-Toledo International, Inc. has a 12 month low of $1,023.05 and a 12 month high of $1,525.17. The stock has a market cap of $28.40 billion, a price-to-earnings ratio of 31.90, a PEG ratio of 2.92 and a beta of 1.23. The stock’s 50 day moving average price is $1,293.20 and its 200 day moving average price is $1,273.15. The company has a debt-to-equity ratio of 159.45, a current ratio of 1.12 and a quick ratio of 0.78.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.78 by $0.68. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The firm had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same period last year, the company posted $10.09 EPS. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 2,240 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $1,432.00, for a total value of $3,207,680.00. Following the sale, the chief financial officer directly owned 5,579 shares in the company, valued at approximately $7,989,128. The trade was a 28.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 240 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total transaction of $342,513.60. Following the completion of the sale, the insider directly owned 259 shares of the company’s stock, valued at $369,629.26. The trade was a 48.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 3,312 shares of company stock valued at $4,750,362 over the last 90 days. 0.71% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

MTD has been the topic of a number of recent analyst reports. Robert W. Baird cut their price target on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. JPMorgan Chase & Co. cut their target price on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Jefferies Financial Group increased their price target on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Morgan Stanley raised their price target on Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Tuesday, August 4th. Finally, Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 4th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and a consensus target price of $1,461.27.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.